AstraZeneca deal: What you need to know about Pfizer's £63bn bid
Pfizer's chief executive Ian Read has admitted jobs will be lost and research spending will be cut if the US pharmaceutical giant succeeds in taking over AstraZeneca in front of MPs.
This is what you need to know about the multi-billion pound deal:
What are today's parliamentary hearings about?
An attempt by the US drugs conglomerate Pfizer to take over the Anglo-Swedish firm AstraZeneca. It has made three bids - the most recent was £63bn - which have been rejected by AstraZeneca's board.
What does AstraZeneca do in the UK?
It employs 6,700 staff, including some 2,600 scientists, at seven sites working on developing medicines and biotechnology.
What about Pfizer?
One of the world's largest pharmaceutical firms, it has around 2,600 British employees.
Who is against the deal?
Unions and the Labour Party have raised fears that the potential acquisition would lead to job losses in Britain and the erosion of the UK's scientific research base. They point to redundancies after Pfizer took over other firms. One former AstraZeneca chief executive has compared the American company to a 'praying mantis'.
Are there other worries?
Pfizer has said it wants to divide the business into three units. Critics fear this could pave the way to break-up of the company. They also claim that the potential move to the UK is prompted by a desire to cut its tax bill.
How has the government reacted?
Initially enthusiastically, with Tory ministers arguing that the deal demonstrated the appeal of Britain to foreign investment. David Cameron said Pfizer had produced 'robust' assurances on jobs and research. Since then, they have tempered their praise, arguing that the important thing is to engage with the US company.
Vince Cable, the Lib Dem Business Secretary, has adopted a more neutral stance.
What has Pfizer promised?
It has promised to keep one-fifth of its scientists in Britain for five years and insists the pledge is legally binding. It has also promised to press ahead with AstraZeneca's plans to build a research centre in Cambridge and to keep open its plant in Macclesfield.
- 1 Malaysia Airlines MH17 crash: Pro-Russian rebel 'admits to shooting down plane'
- 3 Israel-Gaza conflict: The myth of Hamas’s human shields
- 5 Dutch paedophile club to fight their ban at the European Court of Human Rights
Lana Del Rey: 'I have slept with a lot of guys in the industry'
Peaches Geldof cause of death: 'Heroin addict' socialite had taken fatal dose of drug, inquest concludes
Peaches Geldof inquest: Tragic final moments of socialite's life reveal she lied to husband about failed heroin tests
Israel-Gaza conflict: The myth of Hamas’s human shields
Malaysia Airlines MH17 crash: Was a Russian-made missile really parked in this quiet square?
Malaysia Airlines MH17 crash: Vladimir Putin is given 'one last chance' to end hostilities in Ukraine
The 'scroungers’ fight back: The welfare claimants battling to alter stereotypes
The truth about conspiracy theories is that some require considering
Malaysia Airlines MH17 crash: Ukrainian military jet was flying close to passenger plane before it was shot down, says Russian officer
Malaysia Airlines MH17 crash: Massive rise in sale of British arms to Russia
Malaysia Airlines MH17 crash: victims’ bodies bundled in black bags and loaded onto trains
iJobs Money & Business
£350 - £400 per day: Orgtel: PMO Analyst - Banking - London - £350 -£400 per d...
£300 - £350 per day + competitive: Orgtel: Cost Reporting Manager - MI Packs -...
£35000 - £40000 Per Annum plus 23 days holiday and pension scheme: Clearwater ...
£475 - £525 per day: Orgtel: Test Lead, London, Investment Banking, Technical ...